---
ver: rpa2
title: 'MoleCLUEs: Molecular Conformers Maximally In-Distribution for Predictive Models'
arxiv_id: '2306.11681'
source_url: https://arxiv.org/abs/2306.11681
tags:
- uncertainty
- conformers
- molecular
- moleclues
- figure
- transformers
- self-attention
- retrieval-augmented-generation
- instruction-tuning
- parameter-efficient-finetuning
- mixture-of-experts
- chain-of-thought
core_contribution: This paper introduces MoleCLUEs, a method to optimize molecular
  conformers by minimizing predictive uncertainty in structure-based ML models. The
  approach leverages differentiable uncertainty estimators and a novel equivariant
  generative model to iteratively sample latent representations that correspond to
  conformers with lower uncertainty.
---

# MoleCLUEs: Molecular Conformers Maximally In-Distribution for Predictive Models

## Quick Facts
- **arXiv ID**: 2306.11681
- **Source URL**: https://arxiv.org/abs/2306.11681
- **Reference count**: 31
- **Key outcome**: Introduces MoleCLUEs method to optimize molecular conformers by minimizing predictive uncertainty in structure-based ML models

## Executive Summary
MoleCLUEs presents a novel approach for generating molecular conformers that are maximally in-distribution for predictive models by leveraging differentiable uncertainty estimation. The method uses an E3NNV autoencoder architecture combined with gradient-based optimization of latent representations to iteratively produce conformers with reduced epistemic and aleatoric uncertainty. The approach is evaluated on predicting drug clearance rates, demonstrating significant reductions in uncertainty and moderate improvements in prediction accuracy.

## Method Summary
MoleCLUEs operates by encoding 3D molecular conformers into an equivariant latent space using an E3NNV autoencoder, then optimizing these latent representations through gradient descent to minimize both epistemic uncertainty (via orthonormal certificates) and aleatoric uncertainty (via predictive variance). The optimized latent vectors are decoded back into conformers, producing structures that are more consistent with the model's training distribution. The method is trained jointly with a structure-based predictor and evaluated on the TDC dataset's clearance prediction task using held-out test sets with varying noise levels.

## Key Results
- Substantial reductions in both epistemic and aleatoric uncertainty for optimized conformers
- Moderate improvements in target prediction error for drug clearance rates
- Visualizations show conformer optimization trajectories revealing uncertainty sources

## Why This Works (Mechanism)

### Mechanism 1
- **Claim**: Differentiable uncertainty estimators guide latent sampling toward conformers with lower predictive uncertainty.
- **Mechanism**: Gradients of aleatoric and epistemic uncertainty with respect to latent space enable iterative adjustment of latent vectors to reduce uncertainty measures.
- **Core assumption**: Uncertainty gradients provide meaningful directions in latent space corresponding to lower uncertainty conformers.
- **Evidence anchors**: Abstract states differentiable estimates of uncertainties are computed w.r.t. latent posteriors; section describes iterative sampling of new latents in direction of lower uncertainty by gradient descent.
- **Break condition**: If uncertainty landscape is too noisy or flat, gradient descent may not find meaningful directions; if uncertainty estimators are poorly calibrated, gradients may point to irrelevant regions.

### Mechanism 2
- **Claim**: E3NNV AE architecture enables decoding of latent vectors back to conformers while preserving equivariance.
- **Mechanism**: E3NN encoder produces equivariant latent representations, and decoder uses relational graph convolutional network with skip connections to maintain molecular graph structure while generating 3D coordinates.
- **Core assumption**: Equivariant latent space captures sufficient information about conformer geometry for accurate reconstruction.
- **Evidence anchors**: Section states need for decoder module that takes latent vectors as input and outputs position matrices; section describes separate latent distributions for each spherical-harmonic level modeled.
- **Break condition**: If E3NNV AE cannot capture full complexity of conformer geometries in latent space, or if decoder architecture is insufficient, decoded conformers may be poor quality or non-physical.

### Mechanism 3
- **Claim**: Modular uncertainty quantification allows targeting specific sources of uncertainty.
- **Mechanism**: Separation of epistemic uncertainty (via orthonormal certificates) and aleatoric uncertainty (via predictive variance) enables optimization to focus on reducing one or the other depending on specific needs.
- **Core assumption**: Two uncertainty measures are well-calibrated and capture distinct aspects of model uncertainty.
- **Evidence anchors**: Section states separate estimate for different sources in predictive uncertainty is desirable, allowing exploration of different configurations when optimizing conformers; section describes differentiable estimate consisting of orthonormal certificates for epistemic uncertainty and predictive variance for aleatoric uncertainty.
- **Break condition**: If uncertainty measures are not well-calibrated or overlap significantly, targeting one may not provide expected benefits; if uncertainties are too high to be reduced meaningfully, optimization may not converge.

## Foundational Learning

- **Variational Autoencoders**
  - Why needed here: E3NNV AE is a VAE mapping between 3D conformer space and lower-dimensional latent space, enabling efficient optimization.
  - Quick check question: What is the role of the KL divergence term in the VAE loss, and how does it affect the latent space distribution?

- **Uncertainty Quantification in Deep Learning**
  - Why needed here: Method relies on estimating and reducing both epistemic and aleatoric uncertainty to improve conformer quality.
  - Quick check question: How do orthonormal certificates differ from traditional uncertainty measures like dropout or ensemble variance?

- **Equivariant Neural Networks**
  - Why needed here: E3NN architecture ensures model respects symmetries of 3D space, crucial for accurate conformer generation.
  - Quick check question: Why is it important for latent space to maintain equivariance, and how does E3NNV AE achieve this?

## Architecture Onboarding

- **Component map**: Input conformers -> E3NN encoder -> Equivariant latent space -> RGCN decoder with skip connections -> Output position matrices
- **Critical path**: Encoder-decoder pipeline with uncertainty gradients flowing back to latent space is core of method
- **Design tradeoffs**: VAE allows sampling and uncertainty estimation but adds complexity compared to deterministic encoder-decoder; separating uncertainty sources provides flexibility but requires careful calibration
- **Failure signatures**: Poor reconstruction quality in VAE (high Lr loss); non-physical conformers (distorted bond lengths/angles); uncertainty not decreasing despite optimization (flat gradients)
- **First 3 experiments**: 1) Train E3NNV AE on small dataset and visualize latent space to ensure it captures conformer diversity; 2) Implement uncertainty modules and test calibration on held-out data; 3) Run simple optimization on single molecule to see if latent vector moves in meaningful direction when minimizing uncertainty

## Open Questions the Paper Calls Out

- **Future work will investigate the use of physical priors and/or calls to physics-based score functions during CLUE optimization** to potentially improve conformer quality and physical plausibility.

## Limitations

- Architecture specificity: Heavy reliance on E3NNV AE architecture from Maser et al. (2023) without full implementation details creates uncertainty about reproducibility
- Uncertainty calibration: Limited discussion of how well-calibrated epistemic and aleatoric uncertainty estimates are in practice, particularly for complex conformational landscapes
- Generalizability: Evaluation focuses on single drug property prediction task, raising questions about performance on other molecular property prediction tasks or different chemical spaces

## Confidence

- **High Confidence**: Core mechanism of using differentiable uncertainty gradients for latent optimization is well-established and technically sound; integration with E3NN architectures for equivariant learning is robust
- **Medium Confidence**: Claims about substantial uncertainty reduction and moderate prediction error improvements are supported by experimental results but could benefit from broader validation across different tasks and molecular classes
- **Low Confidence**: Assertion that MoleCLUEs provides insights into sources of uncertainty through visualization lacks detailed analysis and could be more speculative than evidence-based

## Next Checks

1. **Architecture Reproducibility Test**: Implement E3NNV AE architecture from scratch using only specifications from Maser et al. (2023) and verify it can reconstruct conformers with similar accuracy to original implementation

2. **Uncertainty Calibration Assessment**: Conduct thorough calibration analysis of both epistemic and aleatoric uncertainty estimates across different molecular classes and noise levels to verify reliability and distinguishability

3. **Cross-Domain Generalization**: Apply MoleCLUEs to at least two additional molecular property prediction tasks (e.g., solubility, binding affinity) to evaluate robustness and identify any task-specific limitations